comparemela.com

Latest Breaking News On - பார்சிலோனா சிகிச்சையகம் கல்லீரல் புற்றுநோய் - Page 1 : comparemela.com

Oncotarget: Inflammatory microenvironment & hepatic macrophage in hepatocellular carcinoma

DOORwaY-90 study for SIR-Spheres® therapy as first-line treatment for hepatocellular carcinoma enrolls first patient

Press release content from PR Newswire. The AP news staff was not involved in its creation. DOORwaY-90 study for SIR-Spheres® therapy as first-line treatment for hepatocellular carcinoma enrolls first patient May 10, 2021 GMT Sirtex DOORwaY-90 Study Logo First prospective multicenter U.S.-based trial for indication expansion of SIR-Spheres® Y-90 resin microspheres taking place in 15 sites across the U.S. WOBURN, Mass., May 10, 2021 /PRNewswire/ Sirtex Medical (“Sirtex”), a leading manufacturer of targeted liver cancer therapies, announced that the first patient has been enrolled in DOORwaY-90, a study evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin microspheres in patients with unresectable hepatocellular carcinoma (HCC).

COVID-19 First Wave Declined Liver Cancer Care

COVID-19 First Wave Declined Liver Cancer Care by Angela Mohan on  February 9, 2021 at 3:15 PM Liver cancer care has been drastically reduced in the view of first wave of COVID-19. The delays of screening programmes, diagnostic imaging and biopsies, cuts in the numbers of physicians available to treat liver cancer patients, cancellations of surgery, and a drop in the number of patients entered on clinical trials, were just some of the issues reported in the poll. The global Liver Cancer Outcomes in COVID-19 (CERO-19) Survey led by the Barcelona Clinic Liver Cancer (BCLC) group from Hospital Clinic of Barcelona, CIBEREH, and the Ospedale Maggiore Policlinico of Milan included 76 high-volume cancer treatment centres which participated during the first wave of the COVID-19 pandemic between March and June 2020, finding that 87% of centres modified clinical practice for liver cancer patients. These centres spanned Europe, North America, South America, Africa, and

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.